Main Topic
In this episode of Oncology Unscripted, Dr Marshall examines the evolving role of blood-based cancer screening and highlights new research showing how dogs may help detect early cancers from breath samples.

Alternative Data Centers, Medicine, and AI Guilt?
In MedBuzz, Dr Marshall discusses the emergence of betting on clinical trial outcomes, the rise of AI in medicine, the environmental impact of data centers, and whether growing reliance on artificial intelligence should leave clinicians with a sense of AI guilt.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Main Topic:
In this episode of Oncology Unscripted, Dr John Marshall discusses major post-ASCO developments in GI oncology, including new RAS inhibitor data in pancreatic cancer and the path forward.

MedBuzz:
In this episode of Oncology Unscripted, Dr John Marshall reflects on a trip to South Africa and what it revealed about survival, inequity, and the luxury of modern cancer care. Through experiences in Johannesburg and on safari, he connects cancer care access to broader questions of privilege, community, and responsibility.

Interview:
In this episode of Oncology Unscripted, Dr John Marshall speaks with global oncology experts about cancer care access and the barriers that limit availability of new treatments and testing worldwide. The discussion examines drug pricing, reimbursement, value, and the need for more equitable access to cancer care.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

MedBuzz:
In this episode of Oncology Unscripted, John Marshall, MD, discusses a troubling week in health care news, including upheaval at the FDA, concerns about reduced federal support for medical education, and growing evidence that AI-generated fabricated references are appearing in published scientific literature.

Main Topic:
In this episode of Oncology Unscripted, Dr John Marshall previews the practice-changing data expected at ASCO 2026, highlighting advances in precision medicine. Tune in to hear which presentations could shape the next wave of cancer care.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.